Early MRI Detection of Myocardial Deterioration as a Preventive, Disease Staging, and Prognostic Biomarker in Insulin Resistance

Trial ID or NCT#

NCT03509441

Status

not recruiting iconNOT RECRUITING

Purpose

The purpose of this study is to evaluate the relationship between insulin resistance (IR) and myocardial tissue abnormalities. The study will focus on a patient population, South Asians, with a high prevalence of IR.

Official Title

Early MRI Detection of Myocardial Deterioration as a Preventive, Disease Staging, and Prognostic Biomarker in Insulin Resistance

Eligibility Criteria

Ages Eligible for Study: 20 Years to 60 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes
Inclusion Criteria:
  1. - South Asian
Exclusion Criteria:
  1. * Pregnant women* Patients with prior diagnoses of diabetes* Patients on insulin therapy* Patients with known coronary heart disease or other non-ischemic cardiomyopathies
View All Criteria
Show Less

Investigator(s)

Rajesh Dash, MD PhD; Director of SSATHI & CardioClick
Rajesh Dash, MD PhD; Director of SSATHI & CardioClick
Cardiologist
Associate Professor of Medicine (Cardiovascular Medicine)
Abha Khandelwal
Abha Khandelwal
Cardiologist, Obstetrics cardiologist
Clinical Associate Professor, Medicine - Cardiovascular Medicine

Contact us to find out if this trial is right for you.

Contact

Krystal Solis
650-723-8138

View on ClinicalTrials.gov